Article
Myostatin: a Circulating Biomarker Correlating with Disease in Myotubular Myopathy Mice and Patients
4 May 2020
Abstract excerpt
Myotubular myopathy, also called X-linked centronuclear myopathy (XL-CNM), is a severe congenital disease targeted for therapeutic trials. To date, biomarkers to monitor disease progression and therapy efficacy are lacking. The Mtm1 −/y mouse is a faithful model for XL-CNM, due to myotubularin 1 ( MTM1 ) loss-of-function mutations. Using both an unbiased approach (RNA sequencing [RNA-seq]) and a directed approach...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
